Skip to main content
. Author manuscript; available in PMC: 2024 May 30.
Published in final edited form as: N Engl J Med. 2023 Nov 30;389(22):2029–2038. doi: 10.1056/NEJMoa2305969

Figure 2. Kaplan–Meier Estimates of the Proportion of Donors Continuing to Receive Vasopressors.

Figure 2.

Shown are survival curves in the intention-to-treat population for the time from initiation of levothyroxine or saline infusion until weaning from vasopressors and inotropes (excluding vasopressin at a dose of <1 unit per hour) in the two trial groups. The shaded bands represent 95% confidence intervals. The proportional-hazards assumption was satisfied.